Alcon stock declines over 10% due to recall by March 2025?
Yes • 50%
No • 50%
Stock market data from financial news websites
Alcon Recalls Systane Eye Drops That May Cause Vision Damage Due to Fungal Contamination
Dec 24, 2024, 06:30 PM
Alcon Laboratories has issued a nationwide recall of certain Systane brand eye drops due to potential fungal contamination that may cause vision damage. The recall affects a single lot of 'Systane Lubricant Eye Drops Ultra SPF, Single Vials On-the-Go' after a consumer reported finding a foreign material in a sealed vial. Upon investigation, the material was identified as fungal. The U.S. Food and Drug Administration announced the voluntary recall, advising consumers to check their medicine cabinets and discontinue use of the affected product.
View original story
Other outcome • 25%
Increase by more than 10% • 25%
No significant change (+/- 10%) • 25%
Decrease by more than 10% • 25%
No significant change • 25%
Other outcome • 25%
Alcon gains market share • 25%
Alcon loses market share • 25%
No significant changes • 25%
Product reformulation • 25%
Increased quality checks • 25%
Discontinue product • 25%
Recall expanded • 25%
No issues found • 25%
Minor compliance issues • 25%
Major compliance issues • 25%
Target • 25%
CVS • 25%
Walgreens • 25%
Other • 25%
Increase by more than 5% • 25%
Fluctuate within 5% • 25%
Decrease by more than 5% • 25%
No significant change • 25%
Switch to alternative brands • 25%
Decreased trust in Alcon • 25%
Increased demand for safer packaging • 25%
No significant change • 25%
No further action • 25%
Fine imposed • 25%
Mandatory product reformulation • 25%
Temporary production halt • 25%